InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: Inoviorulez post# 25871

Thursday, 07/26/2018 10:49:46 AM

Thursday, July 26, 2018 10:49:46 AM

Post# of 233039
This is incorrect. The IDMC has already reviewed the first 10 patients, and they are recruiting 10 more. They loosened the requirements for the next 10 patients and are upping the dose. Pourhassan suggested the second cohort of 10 could be enrolled quickly. The FDA is going to review again after the next 10 (patients 11-20) complete 30 days post-treatment. He did suggest that if data was strong, they may not need to finish enrolling the trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News